Pyrimethamine is an antifolate drug used to treat a variety of infectious diseases, including toxoplasmosis, malaria, and isoniazid-resistant tuberculosis. It is also used to prevent and treat Pneumocystis jirovecii pneumonia in people with weakened immune systems. Pyrimethamine is available in both oral and injectable forms, and is often used in combination with other drugs. The pyrimethamine market is driven by the increasing prevalence of infectious diseases, the growing demand for combination therapies, and the increasing availability of generic drugs. The market is also driven by the increasing number of clinical trials and the development of new formulations. Companies in the pyrimethamine market include GlaxoSmithKline, Pfizer, Merck, Sanofi, Novartis, and Mylan. Show Less Read more
ASK A QUESTION
We request your telephone number so we can contact you in the event we have difficulty reaching you via email. We aim to respond to all questions on the same business day.
